Sector Investors News and Insights

Embecta, a company that specializes in diabetes devices, is considering the possibility of being sold due to declining profits.

Shares are down 70% for the world’s largest maker of insulin pen needles and syringes since it was spun off…

Read More: https://www.ft.com/content/4aa65f0f-dcdf-4849-bd87-b81b23961fc1

More News

© 2025 ETF Sector

Scroll to Top

Subscribe to our Newsletter

Stay updated with the latests analysis and insights fromm etfsector.com

If you haven’t received your newsletter email, check your spam/junk folder and add us to your contacts to ensure delivery.